Literature DB >> 24078164

Circulating C5L2 gene polymorphism is associated with type 2 diabetes mellitus in Saudi population.

Khalid K Alharbi, Imran Ali Khan, Rabbani Syed.   

Abstract

The aim of the present study was to examine the relationship between the novel single nucleotide polymorphism, 698C>T that causes an amino acid change from proline to leucine at codon 233 and type 2 diabetes mellitus (T2DM) in the Saudi population. From the general population in the Saudi Arabia a total of 551 samples were collected and categorized them as T2DM (n = 376) and healthy controls (n = 175). Five ml of the blood sample was collected and used for the Biochemical and Molecular analysis. With the help of serum sample lipid profile: Fasting blood sugar (FBS), Total Cholesterol (TC), Triglycerides (TG), High Density Lipoprotein Cholesterol (HDL-C), Low Density Lipoprotein Cholesterol (LDL-C) and VLDL were performed. PCR–RFLP was performed after separating the genomic DNA from the EDTA blood. The genotype distribution of C698T polymorphism was performed by the Chi square test with SPSS version 16.0 software for comparing T2DM subjects and healthy controls. In our study, genotypic distributions of C5L2 C698T polymorphism and allele frequency of patients and controls were found to be significant difference in the allele and the genotypic distribution. [For T Vs C; p = 0.01; Odds ratio = 3.594 (95 % CI; 1.256–10.28); and CT+TT Vs CC; p = 0.009; Odds ratio = 3.707 (95 % CI; 1.285–10.69)]. TT genotype was completely absent in both the cases and the controls. In conclusion, our study indicates that 698C>T polymorphism of C5L2 gene is associated with the T2DM in individuals of Saudi population which was found to be similar with other studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24078164     DOI: 10.1007/s11033-013-2745-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  15 in total

1.  Diabetes type 2 pandemic in 21st century.

Authors:  E Ginter; V Simko
Journal:  Bratisl Lek Listy       Date:  2010       Impact factor: 1.278

2.  Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.

Authors:  Adriana Huertas-Vazquez; Carlos Aguilar-Salinas; Aldons J Lusis; Rita M Cantor; Samuel Canizales-Quinteros; Jenny C Lee; Lizzette Mariana-Nuñez; Roopa-Metha Laura Riba-Ramirez; Anne Jokiaho; Teresa Tusie-Luna; Päivi Pajukanta
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-23       Impact factor: 8.311

3.  Genetic association of adiponectin gene polymorphisms (+45T/G and +10211T/G) with type 2 diabetes in North Indians.

Authors:  Madhukar Saxena; Neena Srivastava; Monisha Banerjee
Journal:  Diabetes Metab Syndr       Date:  2012-08-24

4.  Heritability of quantitative traits associated with type 2 diabetes mellitus in large multiplex families from South India.

Authors:  Rasika A Mathias; Mohan Deepa; Raj Deepa; Alexander F Wilson; Vishwanathan Mohan
Journal:  Metabolism       Date:  2009-07-01       Impact factor: 8.694

5.  Familial lipoprotein disorders in patients with premature coronary artery disease.

Authors:  J J Genest; S S Martin-Munley; J R McNamara; J M Ordovas; J Jenner; R H Myers; S R Silberman; P W Wilson; D N Salem; E J Schaefer
Journal:  Circulation       Date:  1992-06       Impact factor: 29.690

6.  Induction of insulin resistance by androgens and estrogens.

Authors:  K H Polderman; L J Gooren; H Asscheman; A Bakker; R J Heine
Journal:  J Clin Endocrinol Metab       Date:  1994-07       Impact factor: 5.958

7.  Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: a meta-analysis of 6977 subjects.

Authors:  Yan-Wei Yin; Yun-Dong Zhang; Jing-Zhou Wang; Bing-Hu Li; Qing-Wu Yang; Chuan-Qin Fang; Chang-Yue Gao; Jing-Cheng Li; Li-Li Zhang
Journal:  Gene       Date:  2012-09-13       Impact factor: 3.688

Review 8.  Acylation stimulating protein and triacylglycerol synthesis: potential drug targets?

Authors:  K Cianflone
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

9.  Relationship between a novel polymorphism of the C5L2 gene and coronary artery disease.

Authors:  Ying-Ying Zheng; Xiang Xie; Yi-Tong Ma; Yi-Ning Yang; Zhen-Yan Fu; Xiao-Mei Li; Xiang Ma; Bang-Dang Chen; Fen Liu
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

10.  The interactive effect of SIRT1 promoter region polymorphism on type 2 diabetes susceptibility in the North Indian population.

Authors:  Ekta Rai; Swarkar Sharma; Surabhi Kaul; Kamal Jain; Kawaljit Matharoo; Amarjit S Bhanwer; Rameshwar N K Bamezai
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

View more
  5 in total

1.  Association of interleukin-6 polymorphisms with obesity and metabolic alterations in young Saudi population.

Authors:  Khalid Khalaf Alharbi; Rabbani Syed; Imran Ali Khan
Journal:  Mol Biol Rep       Date:  2014-01-07       Impact factor: 2.316

2.  Association of acylation-stimulating protein and receptor gene polymorphisms with coronary heart disease in Han and Hui populations.

Authors:  Honglei Jiang; Xiangju Liu; Dong Wang; Fang Guo; Jidong Liu; Xiaotang Liang; Zhaoqin Xing; Chunlin Cao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  Genetic polymorphisms in paraoxonase 1 and G protein-coupled receptor 77, and the risk of glucose-6-phosphate dehydrogenase deficiency in a Saudi population.

Authors:  Khalid K Alharbi
Journal:  Saudi Med J       Date:  2015-05       Impact factor: 1.484

Review 4.  The Controversial C5a Receptor C5aR2: Its Role in Health and Disease.

Authors:  Ting Zhang; Malgorzata A Garstka; Ke Li
Journal:  J Immunol Res       Date:  2017-06-15       Impact factor: 4.818

5.  Association of JAZF1 and TSPAN8/LGR5 variants in relation to type 2 diabetes mellitus in a Saudi population.

Authors:  Khalid Khalaf Alharbi; Imran Ali Khan; Rabbani Syed; Fawiziah Khalaf Alharbi; Abdul Khader Mohammed; Benjamin Vinodson; Nasser M Al-Daghri
Journal:  Diabetol Metab Syndr       Date:  2015-10-24       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.